Please login to the form below

Not currently logged in
Email:
Password:

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

Fumie GriegoGlobal pharma association the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has appointed Femie Griego to be its new assistant director general.

She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA).

Prior to that Griego spent time at the White House as its senior economist where she provided US officials in both the Bush and Obama administrations with advice on a range of health and policy issues.

Thomas Cueni, director-general at IFPMA, said: “I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.

“She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”

Griego will join IFPMA's leadership team and will also be working on strengthening the association's work on the industry’s value proposition.

11th May 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics